The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Subscribe To Our Newsletter & Stay Updated
